National Resilience, Inc. clinical trials

The registry lists 37 studies whose lead sponsor is National Resilience, Inc. or one of 2 companies grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 23, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

• 37studies on the registry
• 0open to participants now

Studies

Recruiting first, then most recently updated. Showing 37 of 37.

• Evaluating Technologies for Point-of-Care Blood Collections by PatientsCompletedNCT06507566Not applicable

  Sponsor listed in the registry: Alachua Government Services, Inc. · First submitted after Alachua Government Services, Inc. became part of National Resilience, Inc.

• Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and OlderCompletedNCT00782431Phase 3

  Sponsor listed in the registry: Alachua Government Services, Inc. · First submitted before Alachua Government Services, Inc. became part of National Resilience, Inc.

• Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza InfectionCompletedNCT00800605Phase 3

  Sponsor listed in the registry: Alachua Government Services, Inc. · First submitted before Alachua Government Services, Inc. became part of National Resilience, Inc.

• Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)CompletedNCT01773928Phase 3

  Sponsor listed in the registry: Alachua Government Services, Inc. · First submitted before Alachua Government Services, Inc. became part of National Resilience, Inc.

• Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19CompletedNCT04592549Phase 1

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult SubjectsCompletedNCT04171115Phase 1

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)CompletedNCT00566345Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Reverse Genetic H9N2 Influenza Vaccine Study in AdultsCompletedNCT01320696Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19WithdrawnNCT05142527Phase 2/3

  Sponsor listed in the registry: Resilience Government Services, Inc. · Unclear whether first submitted before or after Resilience Government Services, Inc. became part of National Resilience, Inc.

• Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)WithdrawnNCT04705844Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · Unclear whether first submitted before or after Resilience Government Services, Inc. became part of National Resilience, Inc.

• Yearly Strain Variation Study, 2010/2011CompletedNCT01157702Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy AdultsCompletedNCT03046550Phase 1

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young AdultsCompletedNCT01258062Phase 1

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in AdultsCompletedNCT00895544Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• H5N1 Vaccine Study in Japanese AdultsCompletedNCT01382329Phase 2/3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)CompletedNCT00530660Phase 2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• A/H1N1 Immunogenicity and Safety in AdultsCompletedNCT00959465Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)CompletedNCT00783926Phase 1

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• A/H1N1 Immunogenicity and Safety in Infants, Children and AdolescentsCompletedNCT00976469Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Yearly Strain Variation Study, 2009/2010CompletedNCT00943657Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)CompletedNCT00424086Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801CompletedNCT01604746Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk GroupsCompletedNCT00711295Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)CompletedNCT00289510Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)CompletedNCT00517517Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)CompletedNCT00349141Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Safety and Immunogenicity Study of a Ross River Virus (RRV) VaccineCompletedNCT00717834Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Ross River Virus (RRV) Vaccine StudyCompletedNCT01242670Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and OlderCompletedNCT01774032Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004CompletedNCT00161837Phase 2/3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)CompletedNCT00462215Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Observational Study to Assess Safety of H1N1 Pandemic Influenza VaccineCompletedNCT00950456

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and AdolescentsCompletedNCT01052402Phase 1/2

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Adult Safety Study of 2009/2010 Seasonal Influenza VaccineCompletedNCT01063088Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005CompletedNCT00161811Phase 2/3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Japanese Pediatric H5N1 Vaccine StudyCompletedNCT01911754Phase 3

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.

• Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress DisorderCompletedNCT01492699Not applicable

  Sponsor listed in the registry: Resilience Government Services, Inc. · First submitted before Resilience Government Services, Inc. became part of National Resilience, Inc.